Developed by Glaukos, the founder of minimally invasive glaucoma surgery (MIGS), iStent infinite represents the latest evolution in the iStent family.
With over one million stents implanted globally, iStent infinite is reshaping glaucoma care with refined safety, efficacy, and surgeon-centric design.
Backed by Glaukos’ ongoing commitment to MIGS innovation, iStent infinite introduces several advancements, including the capability to implant three titanium stents spanning six clock hours. This modified design significantly enhances the area of drainage coverage compared to previous models. The newly engineered system supports unlimited delivery attempts, facilitating surgical precision and efficiency.
iStent infinite is indicated for patients with open-angle glaucoma. Performed either as a standalone procedure or in conjunction with cataract surgery, it is designed to provide foundational, continuous therapy that promotes intraocular pressure control and sustained medication reduction.
Visit: glaukos.com
